United Kingdom Brachytherapy Market Insight
Published: 25 May 2026 | Report Format: Electronic (PDF)
The UK brachytherapy market size is rapidly expanding, at about a 6.95% CAGR, and the cancer cases, minimally invasive treatments, and advanced radiation therapy investments
UK Brachytherapy Market Insights Forecasts to 2035
- The UK Brachytherapy Market Size Was Estimated at USD 49.6 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 6.95% from 2025 to 2035
- The UK Brachytherapy Market Size is Expected to Reach USD 97.1 Million by 2035
Notable Insights for UK Brachytherapy Market
- High-dose-rate (HDR) brachytherapy is, kind of leading in the United Kingdom market with close to 53% share, largely pushed by precision oncology demand and more than USD 1.9 billion that has gone into modern radiotherapy systems for prostate, cervical and gynecological cancer care.
- Prostate cancer uses accounts for about 34% of the market, supported by the rising incidence, the spread of screening programs, and around USD 1.3 billion in spending on minimally invasive radiation therapies as well as precision oncology setup across UK healthcare sites.
- In UK government has put in approximately USD 2.3 billion toward cancer care modernization, radiotherapy improvements, diagnostic infrastructure, and precision medicine efforts, so innovation in oncology is getting faster, treatment results are improving, and national healthcare system.
- The United Kingdom sees more than 390,000 new cancer cases every year, which is roughly 0.6% of the total population, and that, alone is creating solid demand for advanced oncology tools, radiation therapy systems, and precision cancer treatment infrastructure in hospitals along with research centers.
Download the eBook (ToC)
Why Buy This Report
- Insights into the UK brachytherapy market, including trends in oncology treatments, advancements in precision radiotherapy, artificial intelligence in cancer care, and modernization of the country’s healthcare infrastructure.
- Analyze the impacts of image-guided radiation systems, personalized oncology treatments, minimally invasive cancer therapies, and innovations in AI-assisted radiotherapy on the UK brachytherapy landscape.
- Determine long-term investments in oncology infrastructure, precision diagnostics, HDR brachy therapy treatments, and modernization of healthcare programs in the country.
- Analyze the effects of evolving regulations related to cancer care, modern healthcare infrastructure developments, and innovations in radiotherapy on the UK brachytherapy industry.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the UK brachytherapy market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United Kingdom Brachytherapy Market
- Elekta AB
- Varian Medical Systems
- Eckert & Ziegler BEBIG
- BD (Becton Dickinson)
- Theragenics Corporation
- IsoRay Inc.
- C.R. Bard Inc.
- GE HealthCare
- Others
Recent Developments:
- In February 2025, Elekta AB advanced AI-assisted brachytherapy planning and image-guided oncology systems across the United Kingdom, investing nearly USD 1.8 billion in precision radiotherapy innovation, strengthening cancer treatment modernization, healthcare infrastructure, and oncology market growth.
- In October 2025, Varian Medical Systems advanced HDR brachytherapy and cloud radiotherapy solutions across the United Kingdom, investing nearly USD 2.1 billion in oncology innovation, improving treatment precision, workflow efficiency, and strengthening the UK brachytherapy market ecosystem.
Market Segmentation:
United Kingdom Brachytherapy Market, By Product Type
- High-Dose-Rate (HDR) Brachytherapy
- Low-Dose-Rate (LDR) Brachytherapy
- Pulse-Dose-Rate (PDR) Brachytherapy
United Kingdom Brachytherapy Market, By Application
- Prostate Cancer
- Cervical Cancer
- Breast Cancer
- Skin Cancer
- Others
United Kingdom Brachytherapy Market, By End User
- Hospitals
- Oncology Treatment Centers
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
United Kingdom Brachytherapy Market, By Technology
- Image-Guided Brachytherapy
- Radioisotope-Based Systems
- AI-Assisted Treatment Planning
- Remote Afterloading Systems
- Others
Expert Views:
The UK brachytherapy market is poised to see robust growth in the coming years because of the adoption of connected cars, growth of electric vehicles, and increasing popularity of artificial intelligence-powered driving experience. The growth in self-driving mobility systems, cloud technology for automobiles, and intelligent transportation networks will further fuel the demand for advanced infotainment systems.
Author: Govind and Krishna By Spherical Insights and Consulting